[1]黄金江 陈国伟 刘丽 曲晓力 贺红英*.复发性子宫内膜癌腹腔镜下切除腹主动脉旁转移淋巴结1例报告[J].中国微创外科杂志,2017,17(3):282-288.
　Huang Jinjiang,Chen Guowei,Liu Li,et al.Laparoscopic Removal of Para-aortic Lymph Node Metastasis From Recurrent Endometrial Cancer: Case Report[J].Chinese Journal of Minimally Invasive Surgery,2017,17(3):282-288.
点击复制

复发性子宫内膜癌腹腔镜下切除腹主动脉旁转移淋巴结1例报告()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
17
期数:
2017年3期
页码:
282-288
栏目:
病例报告
出版日期:
2017-06-20

文章信息/Info

Title:
Laparoscopic Removal of Para-aortic Lymph Node Metastasis From Recurrent Endometrial Cancer: Case Report
作者:
黄金江 陈国伟 刘丽 曲晓力 贺红英*
广西医科大学第四附属医院广西柳州市工人医院妇瘤科，柳州545005
Author(s):
Huang Jinjiang;  Chen Guowei;  Liu Li;  et al.
Department of Gynecologic Oncology, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou 545005, China
关键词:
子宫内膜癌; 复发; 淋巴结转移
Keywords:
Endometrial cancer; Recurrence; Lymph node metastasis
文献标志码:
D
摘要:
本文报道2015年11月对1例复发性子宫内膜癌行腹腔镜下切除腹主动脉旁淋巴结病灶，手术时间145 min，出血量50 ml，术后住院7 d。术后第5天开始化疗，辅助放疗。2016年8月随访未见肿瘤复发。我们认为复发性子宫内膜癌腹主动脉旁淋巴结转病灶可在腹腔镜下切除。
Abstract:
In November 2015, laparoscopic removal of para-aortic lymph node metastasis from recurrent endometrial cancer was conducted. The operation took 145 min, and the amount of bleeding during the operation was 50 ml. The length of postoperative hospitalization was 7 days. The patient began to receive chemotherapy and adjuvant radiation therapy from the fifth day after operation. In August 2016, the follow-up visit showed no tumor recurrence. We think that laparoscopic surgery can be utilized for para-aortic lymph node metastasis from recurrent intrauterine membrane carcinoma.

参考文献/References:

[1]Odagiri T, Watari H, Hosaka M, et al. Multivariate survival analysis of the patients with recurrent endometrial cancer. J Gynecol Oncol,2011,22(1):3-8.
[2]Huijgens AN , Mertens HJ. Factors predicting recurrent endometrial cancer. Facts Views Vis Obgyn,2013,5(3):179-186.
[3]Alay I, Turan T, Ureyen I，et al. Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer. Pathol Oncol Res，2015,21(3):803-810.
[4]Mariani A, Webb MJ, Galli L，et al. Potential therapeutic role of para-aortic lymphadenectomy in node positive endometrial cancer. Gynecol Oncol，2000，76（3）： 348-356.
[5]Barlin JN, Wysham WZ, Ferda AM, et al. Location of disease in patients who die from endometrial cancer: a study of 414 patients from a single institution. Int J Gynecol Cancer，2012,22（9）:1527-1531.
[6]Chan JK, Cheung MK, Huh WK, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer,2006,107(8):1823-1830.
[7]Todo Y, Kato H, Kaneuchi M, et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study):a retrospective cohort analysis.Lancet 2010,375(9721):1165-1172.
[8]Turan T, Yilmaz SS, Hizli D, et al. A prospective evaluation of lymphatic dissemination in endometrial cancer: is it adequate to perform lymph node dissection up to the inferior mesenteric artery. Int J Gynecol Cancer,2011, 21(5):864-869.
[9]Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic disseminationin endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol,2008,109（1）:11-18.
[10]Wang PH, Wen KC, Yen MS, et al. Challenges in the management of recurrent endometrial cancer. J Chin Med Assoc，2016,79(4):171-173.
[11]罗翠珍，张洁清,姚丽军，等.腹腔镜与开腹手术治疗子宫内膜癌的比较.中国微创外科杂志，2014，14（3）:216-219.
[12]Papadia A, Bellati F, Ditto A, et al. Surgical Treatment of recurrent endometrial cancer: time for a paradigm shift. Ann Surg Oncol,2015,22（13）:4204-4210.
[13]Ueda J, Yoshida H, Mamada Y, et al. Surgical resection of a solitary para-aortic lymph node metastasis from hepatocellular carcinoma. World J Gastroenterol,2012,18(23):3027-3031.

备注/Memo

备注/Memo:
*通讯作者，E-mail：hehongying828@outlook.com
更新日期/Last Update: 2017-06-20